Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, ...

Ocular Therapeutix launched new branding and website, focusing on innovative treatments for retinal diseases, particularly wet AMD.

Axpaxli drives Ocular's growth in wet AMD; pivotal Phase 3 data could double its stock or drop it 70%.

It is not, however, usually to blame for blurry vision. A rare exception: Ophthalmic migraines (a.k.a. ocular migraine and retinal migraine). “Stress can lead to migraine issues in the brain, and this ...

Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in ...

June is National Migraine and Headache Awareness Month, a time to raise awareness about the impact of migraine and other headache disorders on Americans.

Scientists have developed new tools to improve gene therapy in advanced stages of inherited retinal diseases (IRDs) such as retinitis pigmentosa and Leber congenital amaurosis.

There’s good news for people with migraine who take common drugs before or during pregnancy—a new study found no increase in neurodevelopmental disorders such as autism and ADHD in their ...

Scientists have shown that a drug approved to treat migraine headaches can also alleviate debilitating non-headache symptoms, such as fatigue, brain fog and blinding light sensitivity, that occur ...

To overcome limitations of current retinal models, discover gene and protein marker expression in large-scale human iPSC-derived retinal organoids.

The drug ubrogepant doesn't just ease the headache of a migraine, but also relieves symptoms like neck stiffness and fatigue if taken early enough ...